Centene Corp. (CNC)
NYSE • Healthcare
Last close at November 20, 2026 at 21:00 UTC
Metrics Over Time
Where the Money Goes
Q3 2026Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Feb 9
in 80 daysQ1 2027% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Centene topped consensus on both the top and bottom line in the third fiscal quarter of 2026, based on preliminary results reported October 27, 2026, with adjusted EPS of $0.58 topping the $0.10 estimate by $0.48 and revenue of $50.647 billion topping the $47.117 billion estimate (+7.5%). Revenue rose roughly 2% to about $50.6 billion from about $49.7 billion a year ago as the managed-care business across Medicaid, Medicare, and Commercial coverage expanded modestly overall. Profitability was pressured, with operating income at roughly -$0.3 billion (a loss) for the quarter. Cash generation also swung negative, as Centene posted negative operating cash flow of about $3.7 billion. Adjusted EPS increased 16% from $0.50 a year ago. For the next period, consensus calls for EPS of -$1.09 on revenue of $45.753 billion.
About Centene Corp.
Centene Corp. is a managed-care company on the NYSE under the ticker CNC that focuses on government-sponsored and commercial health coverage in the United States. Across its health plan and care-delivery operations, it generated $194.8 billion of revenue in FY2025.
Today's Snapshot
CNC closed 2.7% below yesterday's close, while its sector was flat. RBC Capital, an investment bank, raised its price target for Centene to $73.
Trading Volume
Below 10d avg (5.5M)
4.3M
vs S&P 500 Today
Outperforming Market
+0.76%
Updated: November 20, 2026 at 21:14 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$57.52 - $69.06Sell
- RSI (14)39.97Neutral
- Stochastic %K (14, 3, 3)11.58Buy
- MACD Level (12, 26)-0.03Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.